+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cardiomyopathy Drug"

Cardiomyopathies Epidemiology Forecast, 2021-2031 - Product Thumbnail Image

Cardiomyopathies Epidemiology Forecast, 2021-2031

  • Report
  • June 2022
  • 38 Pages
  • Global
From
Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 80 Pages
  • Global
From
Dilated Cardiomyopathy Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Dilated Cardiomyopathy Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 109 Pages
  • Global
From
Hypertrophic Cardiomyopathy Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hypertrophic Cardiomyopathy Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 81 Pages
  • Global
From
Loading Indicator

The Cardiomyopathy Drug market is a subset of the Cardiovascular Drugs market, focusing on drugs used to treat cardiomyopathy, a condition in which the heart muscle becomes weakened or damaged. These drugs are used to reduce symptoms, improve heart function, and reduce the risk of complications. Commonly used drugs include beta-blockers, ACE inhibitors, angiotensin receptor blockers, and diuretics. Other treatments may include lifestyle changes, such as diet and exercise, and surgery. The Cardiomyopathy Drug market is highly competitive, with many companies offering a variety of treatments. Major players in the market include Pfizer, Novartis, Sanofi, Merck, and GlaxoSmithKline. Other companies include AstraZeneca, Bristol-Myers Squibb, and Boehringer Ingelheim. Show Less Read more